IRMD Stock Analysis: Buy, Sell, or Hold?
IRMD - iRadimed Corporation
$97.20
-0.84 (-0.86%)
▼
5d:
-3.73%
30d:
+0.81%
90d:
+1.72%
BUY
HIGH Confidence
Analysis Updated: Jul 10, 2026 12:00 AM ET
Earnings: Aug 07, 2026
24d
Get Alerted When IRMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: IRMD shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: IRMD shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$89.34
Based on 8.8% avg growth
INTRINSIC VALUE TODAY
$55.47
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: IRMD is currently trading at $97.20, which is considered slightly high relative to its 30-day fair value range of $92.13 to $98.15. The stock's valuation (Forward PE: 41.3) is in line with its historical norms (42.1). Remarkably, the market is currently pricing in an annual earnings decline of 0.7% over the next few years. This pessimistic expectation contrasts with the company's recent 22.1% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, IRMD is in a downtrend. Immediate support is located at $92.03, while resistance sits at $102.99.
Market Sentiment: IRMD has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (13th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $118.00 (+21.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, IRMD is in a downtrend. Immediate support is located at $92.03, while resistance sits at $102.99.
Market Sentiment: IRMD has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (13th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $118.00 (+21.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$92.13 -
$98.15
Company Quality Score
65/100
(BUY)
Options IV Signal
13th percentile
(COMPLACENCY WARNING)
Volume Confirmation
HIGH
Confidence Score
80.8%
All Signals
- BULLISH: Options cheap (IV 13th percentile)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 21.4% below Wall St target ($118.00)
Trading Range Analysis
30-Day Trading Range
$92.13 -
$98.15
Current vs Trading Range
SLIGHTLY HIGH
Expected Move (7 Days)
±$6.12
(6.3%)
Support & Resistance Levels
Support Level
$92.04
Resistance Level
$102.99
Current Trend
Downtrend
Technical data as of
Jul 10, 2026
Fundamental Context
Forward P/E (Next Year Est.)
41.27
Wall Street Target
$118.00
(+21.4%)
Revenue Growth (YoY)
12.6%
Earnings Growth (YoY)
22.1%
Profit Margin
27.4%
Valuation Discount vs History
-0.7% cheaper
PE vs Historical
41.3 vs 42.1
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.7%
(market-implied from PE analysis)
1-Year Target
$96.52
(-1%)
2-Year Target
$95.84
(-1%)
3-Year Target
$95.17
(-2%)
3-Yr Target (if PE normalizes)
(PE: 41→42)
$97.08
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 41.3, Growth: 13.5%)
$142.10
(+46%)
Base:
(SPY PE: 21.8, Growth: 13.5%)
$74.98
(-23%)
Bear:
(PE: 18.5, Growth: 13.5%)
$63.74
(-34%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (54x PE), but valuation improves significantly next year (41x PE) as earnings recover.
Trailing PE: 53.57 | Current EPS (TTM): $1.83
Bull Case
$138.78
(+43%)
Analyst growth 28.7%, PE expands to 58.9
Base Case
$126.17
(+30%)
Market implied 28.7%, PE stable at 53.6
Bear Case
$66.67
(-31%)
Severe decline -20.0%, PE contracts to 45.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 41.3 to 42.1
Stabilization Target:
$99.15
(+2.0%)
PE Expansion Potential:
+2.0%
Share & Embed Analysis
Last updated: July 13, 2026 6:14 AM ET
Data refreshes hourly during market hours. Next update: 7:14 AM
Data refreshes hourly during market hours. Next update: 7:14 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IRMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
14
Sells
Net
INSIDERS SELLING
Recent Transactions
Roger E Susi
SELL
2500 shares
2026-04-21
Roger E Susi
SELL
5000 shares
2026-04-20
Roger E Susi
SELL
2500 shares
2026-04-14
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$74 | 65 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$386 | 63 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$116 | 63 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$97 | 66 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$239 | 58 HOLD |
Advanced IRMD Option Strategies
Professional options setups generated by AI based on today's IRMD price and gamma walls.
